Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Aethlon Medical (AEMD) EBIAT (2016 - 2023)

Historic EBIAT for Aethlon Medical (AEMD) over the last 13 years, with Q1 2023 value amounting to -$2.5 million.

  • Aethlon Medical's EBIAT rose 3483.54% to -$2.5 million in Q1 2023 from the same period last year, while for Mar 2023 it was -$11.9 million, marking a year-over-year decrease of 1407.93%. This contributed to the annual value of -$13.4 million for FY2025, which is 966.5% down from last year.
  • Latest data reveals that Aethlon Medical reported EBIAT of -$2.5 million as of Q1 2023, which was up 3483.54% from -$2.8 million recorded in Q4 2022.
  • Aethlon Medical's 5-year EBIAT high stood at -$820939.0 for Q4 2019, and its period low was -$3.8 million during Q1 2022.
  • Its 5-year average for EBIAT is -$2.2 million, with a median of -$2.1 million in 2021.
  • Its EBIAT has fluctuated over the past 5 years, first surged by 5933.89% in 2019, then plummeted by 19775.54% in 2020.
  • Over the past 5 years, Aethlon Medical's EBIAT (Quarter) stood at -$820939.0 in 2019, then tumbled by 197.76% to -$2.4 million in 2020, then dropped by 3.42% to -$2.5 million in 2021, then dropped by 12.73% to -$2.8 million in 2022, then grew by 13.43% to -$2.5 million in 2023.
  • Its EBIAT was -$2.5 million in Q1 2023, compared to -$2.8 million in Q4 2022 and -$3.7 million in Q3 2022.